Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric carboplatin exposure optimization using creatinine and cystatin C
NL-OMON37073Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of carboplatin in cancer, sponsored by Vrije University Medical Center. Primary endpoint: Prediction of carboplatin exposure using creatinine and cystatin C. Started Jan 2009; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON37073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37073.